New York, June 25, 2012 – Robins, Kaplan, Miller & Ciresi L.L.P. is pleased to announce that Jeffrey Hovden has joined the firm as a partner in New York in the firm’s Life Sciences and Hatch-Waxman Intellectual Property Litigation Group with a focus on generic pharmaceutical patent cases under the Hatch-Waxman Act and within the biotechnology industry. Mr. Hovden represents both generic and name-brand clients, and routinely advises clients on their intellectual property portfolios. He previously was a partner at Wilson, Sonsini, Goodrich & Rosati PC.
“We are delighted that Jeff is joining our group. His experience and recognized stature in the Life Sciences industry offers a terrific boost to our capabilities. We are committed to growing the firm’s Life Sciences practice, and his addition is an incredible asset to our clients in this region as well as to our entire Intellectual Property practice nationwide,” said Ronald J. Schutz, Chair, National IP Litigation Group and Regional Managing Partner in New York.
“The lawyers at Robins, Kaplan, Miller & Ciresi L.L.P. are nothing less than excellent and I have witnessed just how committed they are to their clients. I am truly thrilled with the firm’s unique approach to both experienced in-house litigation support and cost-management, such as the firm’s science advisor and Ediscovery groups, and its innovative quarterly Generically Speaking bulletin,” said Mr. Hovden. “These resources directly benefit generic drug clients.”
He is admitted to practice in New York; U.S. District Court for the Eastern and Southern Districts of New York; U.S. Court of Appeals, Federal Circuit; and the U.S. Supreme Court. He is a member of the New York Intellectual Property Law Association, American Intellectual Property Law Association, and the Federal Circuit Bar Association.
Mr. Hovden received his B.A. in Biology and Philosophy, summa cum laude, Phi Beta Kappa, from the University of Minnesota, and his J.D. from Columbia University School of Law where he was also the Notes Editor of the Columbia Journal of Law & the Arts.